Search

Neil Sheather

Neil Sheather has extensive experience in retail and institutional stockbroking, capital raising and initial public offerings in Australia and Asia. He is also a member of the Institute of Company Directors. Mr Sheather is Mejority Capital’s chief executive and director of its wholly owned subsidiaries. He holds a Responsible Manager of Australian Financial Services Licence 485760 and Responsible Officer on Hong Kong License AZJ721. Mr Sheather started his career in the financial markets in 1996 as a SEATS operator with Comsec. He has since held numerous roles on both the buy side and sell side as an equities dealer and derivatives trader. He was managing director of CMC Markets Stockbroking and ASX listed broker, InvestorFirst Securities. Mr Sheather gained extensive international experience, as a founding partner of CFD provider, Markets Plus, where he further strengthened his expertise in trading various asset classes including equities, commodities, currencies and fixed interest. He currently holds an MBA and several financial markets related post graduate qualifications.
Bio last updated 11 Dec 2017

Article Timeline

Access to our data for Neil Sheather is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Neil Sheather is linked to 2 organisations which are included in 2 lists - Public Companies - Industrial and Public Companies - Resources.

To see the data you will need to .

Total Shareholder Return as at 30/04/18

1 year TSR5 year TSR
116thVDM Group100%-33%
356thProteomics International Laboratories17%0%
469thMejority Capital-1%-10%
603rdNorwood Systems-25%0%
756thOBJ-55%20%
721 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Roles

2016
Executive Director, Company Secretary
2014
Chief Executive Officer; Director of Mejority Securities
Year started and most recent title

Revenue

123rd↓Mejority Capital$2.3m
130th↓Proteomics International Laboratories$1.8m
131st↓OBJ$1.8m
134th↓Norwood Systems$1.6m
136th↓VDM Group$1.4m
238 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer